Citi Reiterates Buy Rating on Madrigal Pharmaceuticals (MDGL)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq futures slip on chip weakness; S&P 500 holds gains
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
- Goldman says this FX trade is the best hedge for the AI drawdown
| (NASDAQ: MDGL) | Delayed: 400.43 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $400.43 | 52 Week High | $18.24 | |||
| Open | $400.43 | 52 Week Low | $6.60 | |||
| Day High | $400.43 | P/E | N/A | |||
| Day Low | $400.43 | EPS | $0.00 | |||
| Volume | 3,020 | |||||
